Earnings Feed
Start Free
Home/Filings/3/0000899243-20-011681
3//SEC Filing

Polaris Venture Management Co IV LLC 3

Accession 0000899243-20-011681

CIK 0001327273other
View on SEC.govCompany Profile

Filed

Apr 29, 8:00 PM ET

Accepted

Apr 30, 7:25 PM ET

Size

18.6 KB

Accession

0000899243-20-011681

Insider Transaction Report

Form 3
Period: 2020-04-30
Lyra Therapeutics, Inc.LYRA
Polaris Venture Management Co IV LLC
10% Owner
Holdings

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,841 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,758 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (100,963 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (23,996 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (449 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (98,213 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (93,808 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,892 underlying)
POLARIS VENTURE PARTNERS ENTREPRENEURS FUND IV LP
10% Owner
Holdings

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,892 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (449 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (23,996 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (98,213 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,841 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (93,808 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,758 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (100,963 underlying)
POLARIS VENTURE PARTNERS IV LP
10% Owner
Holdings

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (93,808 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (100,963 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (23,996 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,841 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,758 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,892 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (449 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (98,213 underlying)
Footnotes (3)
  • [F1]The preferred stock is convertible at any time, at the holder's election and has no expiration date. Each share of preferred stock shall be automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering.
  • [F2]The reportable securities are owned directly by Polaris Venture Partners IV, L.P. ("PVP IV"). Polaris Venture Management Co. IV, L.L.C. ("PVM IV") is the general partner of PVP IV. Each of Jonathan A. Flint ("Flint") and Terrance G. McGuire ("McGuire") are the managing members of PVM IV and may be deemed to have shared voting and dispositive power over the shares held by PVP IV. Each of PVM IV, Flint and McGuire disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
  • [F3]The reportable securities are owned directly by Polaris Venture Partners Entrepreneurs' Fund IV, L.P. ("PVPE IV"). PVM IV is the general partner of PVPE IV. Each of Flint and McGuire are the managing members of PVM IV and may be deemed to have shared voting and dispositive power over the shares held by PVPE IV. Each of PVM IV, Flint and McGuire disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Documents

1 file

Issuer

Lyra Therapeutics, Inc.

CIK 0001327273

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001295438

Filing Metadata

Form type
3
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 7:25 PM ET
Size
18.6 KB
View on SEC.gov